Cell-free nucleic acids as biomarkers in cancer patients
Top Cited Papers
- 12 May 2011
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 11 (6) , 426-437
- https://doi.org/10.1038/nrc3066
Abstract
DNA, mRNA and microRNA are released and circulate in the blood of cancer patients. Changes in the levels of circulating nucleic acids have been associated with tumour burden and malignant progression. In the past decade a wealth of information indicating the potential use of circulating nucleic acids for cancer screening, prognosis and monitoring of the efficacy of anticancer therapies has emerged. In this Review, we discuss these findings with a specific focus on the clinical utility of cell-free nucleic acids as blood biomarkers.Keywords
This publication has 182 references indexed in Scilit:
- Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern MexicoGynecologic Oncology, 2010
- Plasma cell‐free DNA in ovarian cancerCancer, 2010
- Flow cytometric analysis of circulating microparticles in plasmaCytometry Part A, 2010
- The first 30 years of p53: growing ever more complexNature Reviews Cancer, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Genomic DNA methylation: the mark and its mediatorsPublished by Elsevier ,2006
- MicroRNA expression profiles classify human cancersNature, 2005
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003